Oramed's Platform Technology In Oral Delivery Of Proteins Gets Patent In Russia

(RTTNews) - Oramed Pharmaceuticals Inc. (ORMP, ORMP.OB), a developer of oral drug delivery systems, was granted a patent from Russia's Federal Service for Intellectual Property, Patents and Trademarks or ROSPATENT for the company's invention, titled "Methods and Compositions for Oral Administrations of Proteins." The patent includes a core concept of the Company's technology for the oral delivery of drugs currently delivered via injection. Oral delivery can greatly improve patient compliance and outcomes, the company said.

Also, this patent was granted in New Zealand, South Africa and China. Oramed's intellectual property portfolio currently comprises nine issued patents and 26 patents pending.